GABAPENTIN ENACARBIL (has an active metabolite) | GABAPENTIN ENACARBIL | ATC N02BF01
NERVOUS SYSTEM MODERATE-TO-SEVERE PRIMARY RESTLESS LEGS SYNDROME (RLS) IN ADULTS ANTIEPILEPTIC POSTHERPETIC NEURALGIA (PHN) GABAB AGONIST | ORAL | SOLUBILITY 0.5 MILLIGRAM / MILLILITER IN WATER | VOLTAGE-GATED CALCIUM CHANNEL (PMID26680202) | Voltage-dependent calcium channel subunit alpha-2,delta-1 UNIPROT P54289 CACNA2D1 -- Voltage-dependent calcium channel subunit alpha-2,delta-2 UNIPROT Q9NY47 CACNA2D2 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |